Smoking and depression;Tabaquismo y depresión

Salud Mental

Volumn 31, Issue 5, 2008, Pages 409-415

  Coutiño, Ana Moreno ^a   Medina Mora Icaza, María Elena ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Epidemiológicas y Psicosociales del Instituto   (Mexico)

Author keywords

Depression; Smoking; Treatment

Indexed keywords

EID: 70449476000     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Organización Mundial de la Salud. Disponible en: http://www.paho.org/english/ad/sde/ra/tobdefault.htm; 2007.
2. Pan American Health Organization. Disponible en: http://www.paho.org/english/ad/sde/ra/tobdefault.htm; 2008.
3. Organización Mundial de la Salud. http://www.who.int/healthinfo/statics/gbdwhoregionprevalence2002.xls; 2008.
4. Encuesta Nacional de Adicciones (ENA) Secretaría de Salud y Consejo Nacional Contra las Adicciones. Disponible en: www.salud.gob.mx; 2002.
5. SSA. Programa Nacional de Salud 2001 - 2006. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/compi/pns20012006.pdf; 2001.
6. Kuri P, González J, Hoy M, Cortés M. Epidemiología del tabaquismo en México. Salud Pública Mex 2006;48:S91-S98.
7. Villatoro J, Hernández I, Hernández H, Fleiz C, Blanco J et al. Encuesta de Consumo de Drogas de Estudiantes III 1991-2003 SEP- INPRFM. México: Disco compacto; ISB-968-7652-42-8; 2004.
8. González-Pier E et al. Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet 2006;368:1608-1618.
9. Meneses F. Cultivo y producción de tabaco en México. En: Valdés R, Lazcano E, Hernández M (ed.). Primer informe sobre el combate al tabaquismo. México ante el convenio marco para el control del tabaco; 2005; p.289-296. Disponible en: http://www.insp.mx/tabaco/informe/parteXI.pdf.
10. Sesma S, Pérez R, Puentes E, Valdés R. 2005 El precio como determinante del consumo de tabaco en México, 1994-2002. En: Valdés R, Lazcano E, Hernández M (ed.). Primer informe sobre el combate al tabaquismo. México ante el convenio marco para el control del tabaco; 2005. Disponible en: http://www.insp.mx/tabaco/informe/parteIV.pdf.
11. Valdés R, Hernández M. La política fiscal aplicada al tabaco en México: 1980-2005. En: Valdés R, Lazcano E, Hernández M (ed.). Primer informe sobre el combate al tabaquismo. México ante el convenio marco para el control del tabaco; 2005; p. 109-113. Disponible en: http://www.insp.mx/tabaco/informe/parteIV.pdf.
12. Reynales-shigematsu LM, Rodríguez-Bolaños RA, Jiménez JA, Juarez- Marquez SA, Castro-Rios A et al. Costos de la atención médica atribuibles al consumo de tabaco en el Instituto Mexicano del seguro Social. Salud Pública Méx 2006;48(1):48-64.
13. Barclay L, Kheyfets S. Tobacco use in Alzheimer's disease. Prog Clin Biol Res 1989;317:189-194.
14. Glassman A, Helzer JE, Covey LS. Smoking, smoking cessation and major depression. JAMA 1990;264:1546-1594.
15. Salín- Pascual R, de la Fuente JR, Galicia-Polo L, Drucker-Colín R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 1995;121:476-479.
16. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995;7:373.
17. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997; 154:263-265.
18. Mihailescu S, Drucker-Colín R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res 2000;31:131-144.
19. Fakhfakh R, Lagrue G. Depression, tobacco dependence and nicotine. Arch Inst Pasteur Tunis 2002;79:65-72.
20. Hiroaki A, Suemaru K, Gomita Y. Neuronal nicotinic receptors and Psychiatric disorders: functional and behavioral effects of nicotine. Japn J Pharmacol 2002; 88:133-138.
21. Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry 2004;55:69-76.
22. Chang G, Sherritt L, Knight JR. Adolescent cigarette smoking and mental health symptoms. J Adolesc Health 2005;36(6):517-22.
23. Crone MR, Reijneveld SA. The association of behavioural and emotional problems with tobacco use in adolescence. Addict Behav 2007;32(8):1692-8.
24. Glasss RM. Blue mood, blackened lungs- depression and smoking. JAMA 1990;264:1583-1584.
25. Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Med 2008;121(4 supl 1): S20/s31.
26. Greer S. Cancer and the mind. Br J Psychiatry 1983; 143:535-543.
27. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.
28. SERSAME. Servicios de Salud Mental. Disponible en: http://sersame.salud.gob.mx/depresion.htm#intro; 2002.
29. Benjet C, Borges GG, Medina-Mora ME, Fleiz-Bautista C, Zambrano- Ruiz J. La depresión con inicio temprano: prevalencia, curso natural y latencia para buscar tratamiento. Salud Pública Mex 2004a;46(5):17-24.
30. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalencia de trastornos mentales y uso de servicios: resultados de la Encuesa Nacional de Epidemiología Psiquiátrica. Salud Mental 2003;26(4): 1-16.
31. Caraveo J, Colmenares E, Saldivar G. Estudio clínico-epidemiológico de los trastornos depresivos. Salud Mental 1999;22:7-17.
32. Stage KB, Glassman AH, Covey LS. Depression after smoking cessation: case reports. J Clin Psychiatry 1996;57:467-469.
33. Lai I, Hon Ch, Tsai S. Association study of nicotinic-receptor variants and major depressive disorder. J Affect Disord 2001;66(1):79-82.
34. Hall SM, Muñoz R, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 1994;62(1):141-146.
35. Munafò MR, Hitsman B, Rende R, Metcalfe C, Niaura R. Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health. Addiction 2008;103(1):162-171.
36. Catley D, Harris KJ, Okuyemi K, Mayo MS, Pankey E et al. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res 2005;7(6):859-870.
37. Kassel JD, Yates M, Brown RA. Baseline reaction time predicts 12-month smoking cessation outcome in formerlydepressed smokers. Psychol Addict Behav 2007; 21(3):415-419.
38. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalence, service use, and demographic correlatos of 12- month DSM-IV psychiatric disorders in México: results from the Mexican National Comorbidity Survey. Psychol Med 2005;35:1773-1783.
39. Medina-Mora ME, Rojas-guiot E, Borges-guimaraes G, Vázquez-Perez L, Fleiz-bautista C et al. Chapter 4-comorbidity: Depression and substance abuse. En: Aguilar-Gaxiola AS, Guillot TP (eds). Depression in Latinos. Springer Science Business Media LLC; 2008; p.73-90 (en prensa).
40. Benjet C, Wagner FA, Borges GG, Medina-Mora ME. The relationship of tobacco smoking with depressive symptomatology in thr Third Mexican National Addictions Survey. TP 2004b;34(5):881-888.
41. Pomerleau CS. Co-factors for smoking and evolutionary psychobiology. Addiction 1997;92(4):397-408.
42. Salín-Pascual R, Drucker-Colín R. A novel effect of nicotine on mood and sleep in major depression. Neuroreport 1998;9:57-60.
43. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, Mizes JS et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999;67:547-554.
44. Pomerleau CS, Marks JL, Pomerleau OF. Who gets what symptom? Effect of psychiatric cofactor and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine Tob Res 2000;2(3):275-280.
45. Moreno-Coutiño A, Calderón-Ezquerro C, Drucker-Colín R. Long term changes in sleep and depressive symptoms of smokers in abstinente. Nicotine Tob Res 2007;9(3): 389-396.
46. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998;17:35-46.
47. Repko M, van den Brink W, Huyser J. Can depressed patients stop smoking? A review. Tijdschr Psychiatr 2007;49(10):753-62.
48. Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Develpoments in pharmacotherapy for tobacco dependence past, present and future. Drug Alcohol Rev 2006; 25(1):59-71.
49. Saxon AJ, Baer JS, Davis TM, Sloan KL, Malte C A et al. Smoking cessation treatment among dually diagnosed individuals: Preliminary evaluation of different pharcotherapies. Nicotine Tob Res 2003;5(4):589-596.
50. Haug NA, Hall SM, Prochaska JJ, Rosen AB, Tsoh JY, et al. Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine Tob Res 2005; 7(2):217-24.
51. Hughes JR. Depression during tobacco abstinence. Nicotine Tob Res 2007;9(4):443-6.
52. Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacoherapy os Smoking Cessation. Arch Fam Med 2000;9:270-281.
53. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;23(17):1195-202.
54. Glover ED, Glover PN. Pharmacologic treatments for the nicotine dependent smoker. Am J Health Behav 2001; 25(3):179-82.
55. Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. Am J Health Behav 2002; 26(3):213-20.
56. Fiore MC, Thompson SA, Lawrence DL, Welsch S, Andrews K et al. Helping Wisconsin women quit smoking: a successful collaboration. WMJ 2000;99(2):68-72.
57. Cornuz J, Pinget C, Gilbert A, Paccaud F. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Clin Pharmacol 2003; 59(3):201-6.
58. Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006;15(4):280-5.
59. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;4(9):685-691.
60. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;23(1):CD000146.
61. Thase ME, Greenhouse JB, Frank E, Reynolds CF 3rd, Pilkonis PA et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54(11):1009-15.
62. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 2005; 66(8):974-81.
63. Wilkes S. Bupropion. Drugs Today (Barc) 2006; 42(10):671-81.
64. Brown RA, Niaura R, Lloyd-richardson EE, Strong DR, Kahler CW et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 2007;9(7):721-30.
65. Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J et al. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 2004;18(4):362-6.
66. Covey LS, Glassman AH, Jiang H, Fried J, Masmela J et al. A randomized trial of bupropion and&or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction 2007;102(8):1292-1302.
67. Haro R, Drucker-Colín R. A two year study on the effects of nicotine and its withdrawal on mood and sleep. Pharmacopsychiatry 2004;37:1-7.